Hope in a Dose: CGT Podcast | Ep. 10 | Regulatory landscape for ATMPs in EU

In this episode, we talk through what sponsors really need to think about when navigating regulatory pathways for cell and gene therapies. We cover everything from early conversations with regulators and managing CMC risk, to using accelerated approval pathways and building a joined‑up regulatory and operational strategy to help get innovative therapies to patients faster.